On Friday, Following Stocks were among the “Top 100 Losers” of U.S. Stock Market: EXCO Resources Inc. (NYSE:XCO), OvaScience, Inc. (NASDAQ:OVAS), Magnum Hunter Resources Corp. (NYSE:MHR), Companhia Siderurgica Nacional (NYSE:SID)
EXCO Resources Inc. (NYSE:XCO), with shares declined -10.20%, closed at $1.76.
OvaScience, Inc. (NASDAQ:OVAS), with shares dropped -9.98%, settled at $43.47.
Magnum Hunter Resources Corp. (NYSE:MHR), with shares dipped -9.78%, and closed at $2.49.
Companhia Siderurgica Nacional (NYSE:SID), plummeted -9.19%, and closed at $1.68.
Latest NEWS regarding these Stocks are depicted underneath:
EXCO Resources Inc. (NYSE:XCO)
EXCO Resources Inc. (XCO), took part in the 43rd Annual Scotia Howard Weil Energy Conference in New Orleans, Louisiana. Hal Hickey, President and COO, and Ricky Burnett, Vice President, CFO and CAO, presented at the conference on Thursday, March 26, 2015.
EXCO Resources, Inc., an independent oil and natural gas corporation, engages in the attainment, exploration, exploitation, development, and production of onshore oil and natural gas properties with a focus on shale resource plays in the United States.
OvaScience, Inc. (NASDAQ:OVAS)
OvaScience, Inc. (OVAS), declared that additional clinical experience of the Corporation’s AUGMENTSM treatment demonstrated improved pregnancy rates in women who had failed three to seven preceding in vitro fertilization (IVF) cycles. These results were stated at the Society for Reproductive Investigation (SRI) 62nd Annual Scientific Meeting being held in San Francisco, CA. The AUGMENT treatment is not accessible in the United States.
Kutluk Oktay, M.D., F.A.C.O.G, of Gen-art IVF in Ankara, Turkey, and one of the initial IVF specialists to use the AUGMENT treatment in clinical practice, presented initial clinical experience in eight women whose ages ranged between 27 and 41 years with three or more IVF failures and poor egg and embryo quality. In eight women who received the AUGMENT treatment, there were two clinical pregnancies out of eight embryo transfers (25%).
Most notably, the two pregnancies occurred with single embryo transfers in women aged 34 and 41 who had formerly failed to become pregnant following seven and three IVF cycles, respectively. One patient has an ongoing clinical pregnancy.
“These initial AUGMENT pregnancy rates are quite encouraging, especially given that these were women who had failed multiple IVF cycles and were running out of options to use their own eggs,” said Dr. Oktay. “We were also happy to see these pregnancy rates achieved with single embryo transfers during IVF, a practice that may limit the number of multiple births, which can cause health risks to the mother and infant during pregnancy and delivery and after. Based on our experiences to date, the AUGMENT treatment appears to benefit women with poor egg quality and we look forward to ongoing to share our clinical experiences.”
OvaScience, Inc., a life science corporation, engages in the discovery, development, and commercialization of new treatments for infertility. The corporation’s patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman’s own ovaries.
Magnum Hunter Resources Corp. (NYSE:MHR)
Formerly on March 16, Eureka Hunter Pipeline, LLC, in which Magnum Hunter Resources Corp. (MHR), declared that throughput volumes on Eureka Hunter’s gas gathering pipeline system located in West Virginia and Ohio, have now reached a new record of about 623,713 MMBtu per day on Friday, March 13, 2015.
Magnum Hunter Resources Corporation, an independent oil and gas corporation, explores for, exploits, attains, develops, and produces crude oil, natural gas, and natural gas liquid resources in the United States. The corporation operates through the U.S. Upstream, Midstream, and Oilfield Services segments.
Companhia Siderurgica Nacional (NYSE:SID)
Formerly on March 12, Companhia Siderurgica Nacional (SID), declared Fourth-quarter adjusted EBITDA amounted to R$1.0 billion, 3% higher than in 3Q14, largely due to the steel segment, while the adjusted EBITDA margin widened by 2 p.p. to 25% in the same period.
Steel segment EBITDA totaled R$723 million in 4Q14, a 10% quarter-on-quarter improvement, with an EBITDA margin of 27%, 3 p.p. higher than in 3Q14, while In 2014, adjusted steel segment EBITDA came to R$2.9 billion, 20% up on the year before, accompanied by an adjusted EBITDA margin of 26%, growth of 6 p.p. over 2013.
Companhia Siderúrgica Nacional operates as an integrated steel producer primarily in Brazil. It operates through five segments: Steel, Mining, Cement, Logistics, and Energy. The corporation primarily produces carbon steel and various steel products for automotive, home appliance, packaging, construction, and steel processing industries.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
